Volume 30
Number 2
May 2022
Back to issue
Case Reports
F. van Gorp, A.L.M. Vlek, C.M. Pleizier, L.E.M. Haas

Voriconazole is commonly used for the treatment of invasive pulmonary aspergillosis. Recent guidelines strongly advise routine therapeutic drug monitoring for patients receiving voriconazole. We present a case with subtherapeutic voriconazole serum levels caused by drug interactions and genetic polymorphisms.

Back to issue - Download PDF